AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 49 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,465,000 | -74.0% | 500,000 | +25.0% | 0.31% | -72.7% |
| Q1 2018 | $5,632,000 | +19.7% | 400,000 | 0.0% | 1.14% | +3.3% |
| Q4 2017 | $4,704,000 | -17.1% | 400,000 | 0.0% | 1.10% | -8.5% |
| Q3 2017 | $5,676,000 | +34.5% | 400,000 | +33.3% | 1.20% | +37.4% |
| Q2 2017 | $4,221,000 | +12.4% | 300,000 | +33.3% | 0.88% | +25.3% |
| Q1 2017 | $3,755,000 | +1.1% | 225,000 | 0.0% | 0.70% | -21.7% |
| Q4 2016 | $3,715,000 | +11.2% | 225,000 | -10.0% | 0.89% | +64.9% |
| Q3 2016 | $3,340,000 | – | 250,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,265,880 | $6,639,000 | 0.60% |
| Ghost Tree Capital, LLC | 500,000 | $1,465,000 | 0.31% |
| Baker Brothers Advisors | 10,934,154 | $32,037,000 | 0.21% |
| MYDA Advisors LLC | 100,000 | $293,000 | 0.16% |
| Prosight Management, LP | 56,650 | $166,000 | 0.09% |
| Telemetry Investments, L.L.C. | 45,470 | $133,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 480,108 | $1,407,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 186,443 | $546,000 | 0.03% |
| Kalos Management, Inc. | 16,650 | $46,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 46,376 | $136,000 | 0.02% |